Historical review of BCG vaccine in Japan

Japanese Journal of Infectious Diseases

Volumn 60, Issue 6, 2007, Pages 331-336

  Yamamoto, Saburo ^a,b,c   Yamamoto, Toshiko ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; PRESERVATIVE;

AMPOULE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIABILITY; BCG VACCINATION; CLINICAL TRIAL; DNA MICROARRAY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; DRUG STERILITY; FREEZE DRYING; GENETIC TRAIT; GENOME ANALYSIS; HISTORICAL RESEARCH; HUMAN; IMMUNE RESPONSE; JAPAN; LYMPHADENITIS; MOISTURE; MYCOBACTERIOSIS; ORGANOLEPTIC PROPERTY; OSTEITIS; QUALITY CONTROL; REVIEW; STAINING; SUNLIGHT PROTECTION; TUBERCULOSIS; VACCINE PRODUCTION;

BCG VACCINE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; JAPAN; MYCOBACTERIUM BOVIS; QUALITY CONTROL; TUBERCULOSIS; VACCINATION;

EID: 36549081372     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Huebner, R.E. (1996): BCG vaccination in the control of tuberculosis. Curr. Top. Microbiol. Immunol., 215,263-282.
2. Aronson, J.D., Aronson, C.F. and Taylor, H.C. (1958): A twenty years appraisal of BCG vaccination in the control of biberculosis. Arch. Intern. Med., 101, 881-893.
3. Rosenthal, S.R., Loewinsohn, E., Graham, M., et al. (1961): BCG vaccination against tuberculosis in Chicago. A twenty-year study statistically analyzed. Pediatrics, 28, 622-641.
4. Hatt, P.D. and Sutherland, I. (1977): BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Med. J., 2, 293-295.
5. Vandiviere, H.M., Dworski, M., Melvin, I., et al. (1973): Efficacy of bacillus Calmette-Guerin and isoniazid-resistant bacillus Calmette-Guerin with and without isoniazid with and without isoniazid chemoprophylaxis from day of vaccination. Am. Rev. Respir. Dis., 108, 301-313.
6. Frimodt-Moller, J., Acharyulu, G.S. and Kesava, P.K. (1973): Observations on the protective effect of BCG vaccination in a South Indian rural population: fourth report. Bull. Int. Union Tuberc., 48, 40-49.
7. Comstock, G.W. and Webster, R.G. (1969): Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population. Am. Rev. Respir. Dis., 100, 839-845.
8. Comstock, G.W., Woolpert, S.F. and Livesay, VT. (1976): Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep., 91, 276-280.
9. Comstock, G.W., Livesay, VT. and Woolpert, S.F. (1974): Evaluation of BCG vaccination among Peurto Rican children. Am. J. Public Health, 64, 283-291.
10. Tripathy, S.P. (1987): Fifteen-year follow-up of the Indian BCG prevention trial. Bull. Int. Union Tuberc., 62, 69-72.
11. Smith, P.G. (1987): Case-control studies of the efficacy of BCG against tuberculosis. Bull. Int. Union Tuberc., 62, 73-79.
12. World Health Organization (2004): BCG vaccine. Wkly. Epidemiol. Rec., 79, 27-38.
13. Rodrigues, L., Diwan, V and Wheeler, J. (1993): Protective effect of BCG against tuberculosis meningitis and military tuberculosis: A meta-analysis. Int. J. Epidemiol., 22, 1154-1158.
14. Colditz, G., Brewer, T., Berkey, C., et al. (1994): Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA, 271, 698-702.
15. Lotte, A., Wasz-Hockert, O., Poisson, N., et al. (1984): BCG complications: estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res., 21, 107-193.
16. Gheorghiu, M. (1978): Potency and suppurative adenitis in BCG vaccination. Dev. Biol. Stand., 41, 79-84.
17. Muzy, S.G.R., Sant'Anna, C.C., Lapane, S.P.R., et al. (1983): Intradermal BCG vaccination complications - analysis of 51 cases. Tubercle, 64, 23-27.
18. Kroger, L., Korppi, M., Brander, E., et al. (1995): Osteitis caused by bacillus Calmette-Guerin vaccination: A retrospective analysis of 222 cases. J. Infect. Dis., 172, 574-576.
19. Bergdahl, S., Fellander, M. and Robertson, B. (1976): BCG osteomyelitis: experience in the Stockholm region over the years 1961 - 1974. J. Bone Joint Surg., 58B, 212-216.
20. Vanicek, H. (1989): Complications after initial BCG vaccination in a 5-year period in the East Bohemia region. Cesk. Pediatr., 43, 23-26.
21. Bottiger, M. (1982): Osteritis and other complications caused by generalized BCGitis. Acta Paediatr. Scand., 71, 471-478.
22. Lotte, A., Wasz-Hockert, O., Poisson, N., et al. (1988): Second I.U.A.T.L.D. study on complications induced by intradermal BCG vaccination. Bull. Int. Union Tuberc., 63, 47-59.
23. Special Program on AIDS and Expanded Programme on Immunization (1987): Consultation on human immunodeficiency virus (HIV and routine childhood immunization. Wkly. Epidemiol. Rec., 62, 297-304.
24. Brosch, R. and Behr, M.A. (2006): Tuberculosis and the Tubercle Bacillus. In Cole, S.T., Eisenach, K.D., McMurray, D.N. and Jacobs, W.R., Jr. (eds.). p. 155-164. American Society ofMicrobiology, Washington, D.C.
25. Behr, M.A., Wilson, M.A., Gill, W.P., et al. (1990): Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 284,1520-1523.
26. Gordon, S.V., Brosch, R., Billault, A., et al. (1990): Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol., 32, 643-655.
27. Belley, A., Alexander, D., Di Pietrantonio, T., et al. (2004): Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect. Immun., 72, 2803-2809.
28. Mostowy, S., Tsolaki, A. G., Small, P.M., et al. (2003): The in vitro evolution of BCG vaccines. Vaccine, 21, 4270-4274.
29. Bedwell, J., Kairo, S.K., Behr, M., et al. (2001): Identification of substrains of BCG vaccine using multiplex PCR. Vaccine, 19, 2146-2151.
30. Honda, I., Seki, M., Ikeda, N., et al. (2006): Identification of two subpopulations of Bacillus Calmette-Guerin (BCG) Tokyo 172 substrain with different RD16. Vaccine, 24, 4969-4974.
31. Brosch, R., Gordon, S.V, Gamier, T., et al. (2007): Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl. Acad. Sci. USA, 104, 5596-5601.
32. Ferguson, R.G. and Simes, A.B. (1949): BCG vaccination of Indian infants in Saskatchewan. Tubercle, 30, 5-11.
33. Coetzee, A.M. and Bedak, J. (1968): BCG in the prevention of tuberculosis in an adult population. Proc. Mine Med. Off. Assoc., 48, 41-53.
34. Davids, V, Hanekom. W.A., Mansoor, N., et al. (2006): The effect of bacilli Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J. Infect. Dis., 193, 531-536.
35. Davids, V., Hanekom, W., Gelderbloem, S.J., et al. (2007): Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates. Clin. Vaccine Immunol., 14, 198-200.
36. Yamamoto, T., Phalen, S., Uchida, K., et al. (2000): Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis. Kekkaku 75, 379-388 (in Japanese).